已收盘 02-16 16:00:00 美东时间
0.000
0.00%
HC Wainwright & Co. analyst Douglas Tsao reiterates Outlook Therapeutics (NASDAQ:OTLK) with a Buy and maintains $30 price target.
08-15 19:52
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-15 19:51
Outlook Therapeutics press release (NASDAQ:OTLK): Q3 Non-GAAP EPS of -$0.83 beats by $0.01. As of June 30, 2024, Outlook Therapeutics had cash and cash equivalents of $32.0 million. More on Outlook Th...
08-14 19:24
Outlook Therapeutics Inc Q3 Shr View $-1.02 -- LSEG IBES Data
08-14 19:14
Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate of $(1.01) by 17.82 percent. This is a 39.86 percent increase over losses of $(1.38) per share
08-14 19:06
Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2...
08-14 19:05
Outlook Therapeutics (NASDAQ:OTLK) is scheduled to announce Q3 earnings results on Wednesday, August 14th, before market open. The consensus EPS Estimate is -$0.84 (-950.0% Y/Y) and the consensus Reve...
08-14 01:18
Outlook Therapeutics® Announces UK Mhra Marketing Authorization of Lytenava™ (B...
07-08 20:35
Watch the "What This Means" video here Outlook CEO, Russ Trenary underscores th...
06-06 22:30